DaVita (DVA) Q3 2025 10-Q Quarterly Report
Filed: Oct 29, 2025Period ending Sep 30, 2025
Health Care
Services-Misc Health & Allied Services, NECSEC EDGAR DaVita (DVA) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 29, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
DaVita Q3 2025 10-Q Analysis
Management Discussion & Analysis
- • Total consolidated revenue $10.02B YTD Q3 2025 vs. $9.52B YTD Q3 2024, up 5.3%; U.S. dialysis revenue $8.72B up 2.5%, ancillary services $1.36B up 25.5%
- • U.S. dialysis operating income $1.53B YTD Q3 2025 vs. $1.63B YTD Q3 2024, down 5.9%; adjusted operating income $1.55B down 2.3%
- • Best performing segment: International ancillary services revenue +36.2% YTD; worst: U.S. IKC operating loss increased to $24M from $48M loss YTD
- • Operating cash flow $1.35B YTD, down 8.7%; free cash flow decreased 18.8% to $— (value not explicitly given); repurchased 10M shares for $1.46B (+43.4% YoY)
- • Management cautious due to cybersecurity incident and federal government shutdown impacting operations, expects continued expense pressures and operational uncertainties
Risk Factors
- • No new or materially changed risk factors since 2024 10-K filing
- • Regulatory risk from potential changes in Medicare and Medicaid reimbursement rates, ongoing impact on revenue stability
- • Competitive risk from industry consolidation affecting market share and pricing power in dialysis services
- • Operational risk from reliance on staffing and facility management affecting service continuity and patient care quality
- • Financial risk from exposure to reimbursement rate fluctuations impacting cash flow and liquidity management
DaVita Q3 2025 Quarterly FinancialsXBRL
Revenue
$3.4B
▲ +4.8% YoY▲ +1.2% QoQ
Net Income
$150M
▼ -30.0% YoY▼ -24.6% QoQ
Operating Margin
14.8%
▼ -160bp YoY▼ -113bp QoQ
Net Margin
4.4%
▼ -218bp YoY▼ -150bp QoQ
ROE
-26.3%
Total Assets
$17.6B
EPS (Diluted)
$2.05
▼ -18.3% YoY▼ -20.2% QoQ
Operating Cash Flow
$842M
▲ +3.8% YoY▲ +159.5% QoQ
Source: XBRL data from DaVita Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other DaVita Quarterly Reports
Get deeper insights on DaVita
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.